TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›OSRH›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

OSR Health, Inc. (OSRH) financials

Income statement

OSR Health, Inc. (OSRH) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue———$3.53M$2.91M
Revenue growth————-17.7%
Gross profit———$811K$593K
Gross margin———23.0%20.4%
Operating income-$3.31K-$35.4K-$1.83M-$11.7M-$18.3M
Operating margin———-331.2%-631.0%
Net income-$3.31K-$35.4K$404K-$10.3M-$27.1M
Net margin———-292.6%-931.2%
EPS (diluted)$0.00-$0.01$0.05-$4.79-$0.80

Cash flow

OSR Health, Inc. (OSRH) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow-$461.00-$4.24K-$819K-$1.85M-$4.33M
Share buybacks——$36.0M$36.2M—

Balance sheet

OSR Health, Inc. (OSRH) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$4.76K$125K$15.4K$342K$1.70M
Total assets$705K$1.23M$36.6M$175M$171M
Total liabilities$707K$1.26M$4.11M$32.0M$44.2M
Long-term debt———$498K—
Shareholders' equity-$2.12K-$37.5K$153M$143M$127M
Retained earnings-$27.1K-$62.5K-$3.91M-$19.2M-$37.2M
Shares (wtd avg diluted)1.73M1.50M7.72M2.15M22.6M

Every figure is extracted from OSR Health, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is OSR Health, Inc.'s annual revenue?
OSR Health, Inc. (OSRH) reported $2.91M of revenue for fiscal year 2025 — down 17.7% from $3.53M in FY2024, per its annual report filed with the SEC.
Is OSR Health, Inc. profitable?
Not in FY2025 — OSRH reported a net loss of $27.1M, per SEC filings.
Does OSRH pay a dividend?
OSR Health, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full OSRH analysis — verdict, score & filings →Is OSRH a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.